Skip to main navigation Skip to search Skip to main content

A nonsynonymous variant I248L of the adenosine A3 receptor is associated with coronary heart disease in a latvian population

  • Latvian Institute of Organic Synthesis
  • Paula Stradina Clinical University Hospital

Research output: Contribution to journalArticlepeer-review

9 Citations (Scopus)

Abstract

Adenosine plays an important part in the cardiac response to ischemia and reperfusion. The human adenosine receptor A3 (A 3R), along with other adenosine receptors, is involved in mediation of those effects. The aim of the study was to ascertain whether the nonsynonymous single-nucleotide polymorphism (SNP) I248L (reference SNP ID: rs35511654) located in the A 3R gene is associated with coronary heart disease (CHD). DNA samples from 683 individuals with CHD and from 826 control subjects selected from the Latvian Genome Database were successfully screened for rs35511654 using the TaqMan SNP Genotyping Assay. We observed a significantly decreased frequency of the rs35511654 C allele in a group of CHD patients compared with that in controls (p=0.009). The association remained significant after adjustment for age, sex, and other nongenetic factors (p=0.02). These results suggest that A allele of rs35511654 may predispose to CHD.

Original languageEnglish
Pages (from-to)907-911
Number of pages5
JournalDNA and Cell Biology
Volume30
Issue number11
DOIs
Publication statusPublished - 1 Nov 2011

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'A nonsynonymous variant I248L of the adenosine A3 receptor is associated with coronary heart disease in a latvian population'. Together they form a unique fingerprint.

Cite this